Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

FDA chief's long-promised opioid review faces skepticism

The head of the Food and Drug Administration says a comprehensive review of the opioid painkillers that triggered the nation's ongoing overdose epidemic is in the works

The Independent UK

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Is Abbott Labs A "Strong Buy" After Earnings?

Leading healthcare company Abbott Laboratories (ABT) reported strong second-quarter results. And given the company is well-positioned to capitalize on its diverse business and recent FDA approvals, is it wise to buy the stock now? Let’s find out.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Nature is the world's original pharmacy – returning to medicine's roots could help fill drug discovery gaps

While humans evolved over a period of approximately 6 million years, breakthroughs in modern medicine as we know it today got going only in the 19th and 20th centuries. So how did humans successfully survive through millions of years of diseases and illnesses without modern drugs and treatments?

The Conversation

The Truth About Eating Ice Cream In The Summertime

In 1984, President Ronald Reagan declared the third Sunday of each July to be “National Ice Cream Day,” and it doesn’t seem like a coincidence that he picked a date in the middle of the hottest month in the United States, climatologically speaking, to commemorate a treat enjoyed by more…

Zenger

Chuck Schumer Learned Nothing From the Failure of Pot Legalization in California

The Senate majority leader’s marijuana bill would pile on more taxes and regulations, despite years of complaints about the barriers they create.

Reason

Psychedelics And The National Institutes Of Health—How Do They Relate?

As David Hodes first noted in The Green Market Report, the U.S. National Institutes of Health (NIH)’s growing interest in psychedel

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Recap Of Tuesday's Biotech Catalysts - End of The Day Summary

European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis. AbbVie shares traded in a range of $150.33 to $153.56 on a day volume…

Benzinga

Some people with epilepsy find relief with CBD — but the market is murky

The federal government has legalized cannabidiol (CBD). The FDA also has approved one cannabis-derived prescription drug, Epidiolex, for three rare seizure conditions.

Inverse

Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Reformulated COVID vaccine boosters may be available earlier than expected

The Biden administration may scrap plans to expand eligibility for second boosters to younger adults. Instead, it's trying to speed up the next generation of boosters targeting the omicron variant.

WEKU

Parents become drug developers to save their children’s lives

Maggie Carmichael wasn’t developing like other kids. As a toddler, she wasn’t walking and had a limited vocabulary for her age.

Tribune News Service

Why Ketamine-Assisted Psychotherapy May Be The New Vanguard Of SUD Treatment

By Peter Loeb, CEO of Lionrock

Benzinga

My Baby Needed Special Formula From Europe. U.S. Trade Policy Made It Almost Unobtainable.

The FDA should not stand in the way of parents doing what’s best for their children.

Reason

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

5 things to know about the FDA's flawed approach to accelerated drug approvals

An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA's accelerated approval of drugs for urgent medical needs.

Benzinga

RLX Burns Down, But Not Out, With New Licensing Announcement

Key Takeaways: RLX has received a new manufacturing license as required under a new regulation announced earlier this year The license permits the company to produce rechargeable vaping devices at levels about 30% lower than its sales last year By Doug Young

Benzinga

Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

GoodToKnow

Does sun cream go out of date? Plus, the signs it has expired

We asked doctors and a pharmacist to tell us does sun cream go out of date, and how to tell if it has expired, to make sure you and your family are getting the best protection

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Boost now or wait? Many wonder how best to ride out COVID's next wave

Gwyneth Paige didn’t want to get vaccinated against COVID-19 at first. With her health issues — hypertension, fibromyalgia, asthma — she wanted to see how other people fared after the shots. Then her mother got colon cancer.

360info

How the pandemic set back drug safety

The best form of inspection is an unannounced one, but the pandemic changed the game for regulators. They’ll need to work together to protect consumers.

Miami Herald

Monkeypox has been declared a global emergency. Should you get a vaccine? And which one?

Should you get a monkeypox vaccine?

The Guardian - US

Critical elements of leading Alzheimer’s study possibly fraudulent

The highly influential paper, first published in 2006, has helped guide billions of dollars in US federal research into the disease

The Guardian - US

Paxlovid going underused due to doctors’ ‘misperceptions’, experts say

Clinicians are ‘skittish’ about the Covid antiviral, resulting in a failure to treat patients who could greatly benefit

Benzinga

Recap Of Friday's Biotech Catalysts - End Of The Day Summary

Bristol Myers Squibb (NYSE:BMY) received European Medicines Agency (EMA) Positive CHMP Opinion recommending approval for Opdualag (nivolumab and relatlimab) for treatment of patients with Unresectable or Metastatic Melanoma based on results from the Phase 2/3 RELATIVITY-047 trial. Bristol Myers shares traded in a range of $72.48 to $73.61 on a…

Inverse

Overturning Roe leaves people with autoimmune conditions in danger

People with inflammatory arthritis like rheumatoid arthritis are having trouble getting methotrexate in the wake of abortion bans.

1 … 189 190 191 192

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.